22nd Century Group, Inc.

XXII plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, XXII stands at 1.3M. In comparison, PM has a market cap of 255.3B. Regarding current trading prices, XXII is priced at $2.54, while PM trades at $166.81.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

XXII currently has a P/E ratio of N/A, whereas PM's P/E ratio is 24.27. In terms of profitability, XXII's ROE is -5.42%, compared to PM's ROE of -0.74%. Regarding short-term risk, XXII is more volatile compared to PM. This indicates potentially higher risk in terms of short-term price fluctuations for XXII.Check PM's competition here

XXII plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, XXII stands at 1.3M. In comparison, BTI has a market cap of 122B. Regarding current trading prices, XXII is priced at $2.54, while BTI trades at $56.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

XXII currently has a P/E ratio of N/A, whereas BTI's P/E ratio is 30.19. In terms of profitability, XXII's ROE is -5.42%, compared to BTI's ROE of +0.06%. Regarding short-term risk, XXII is more volatile compared to BTI. This indicates potentially higher risk in terms of short-term price fluctuations for XXII.Check BTI's competition here

XXII plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, XXII stands at 1.3M. In comparison, MO has a market cap of 105B. Regarding current trading prices, XXII is priced at $2.54, while MO trades at $63.23.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

XXII currently has a P/E ratio of N/A, whereas MO's P/E ratio is 12.09. In terms of profitability, XXII's ROE is -5.42%, compared to MO's ROE of -2.82%. Regarding short-term risk, XXII is more volatile compared to MO. This indicates potentially higher risk in terms of short-term price fluctuations for XXII.Check MO's competition here

XXII plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, XXII stands at 1.3M. In comparison, RLX has a market cap of 2.7B. Regarding current trading prices, XXII is priced at $2.54, while RLX trades at $2.26.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

XXII currently has a P/E ratio of N/A, whereas RLX's P/E ratio is 31.86. In terms of profitability, XXII's ROE is -5.42%, compared to RLX's ROE of +0.04%. Regarding short-term risk, XXII is more volatile compared to RLX. This indicates potentially higher risk in terms of short-term price fluctuations for XXII.Check RLX's competition here

XXII plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, XXII stands at 1.3M. In comparison, VGR has a market cap of 2.4B. Regarding current trading prices, XXII is priced at $2.54, while VGR trades at $14.99.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

XXII currently has a P/E ratio of N/A, whereas VGR's P/E ratio is 11.90. In terms of profitability, XXII's ROE is -5.42%, compared to VGR's ROE of -0.20%. Regarding short-term risk, XXII is more volatile compared to VGR. This indicates potentially higher risk in terms of short-term price fluctuations for XXII.Check VGR's competition here

XXII plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, XXII stands at 1.3M. In comparison, TPB has a market cap of 1.5B. Regarding current trading prices, XXII is priced at $2.54, while TPB trades at $87.82.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

XXII currently has a P/E ratio of N/A, whereas TPB's P/E ratio is 30.22. In terms of profitability, XXII's ROE is -5.42%, compared to TPB's ROE of +0.22%. Regarding short-term risk, XXII is less volatile compared to TPB. This indicates potentially lower risk in terms of short-term price fluctuations for XXII.Check TPB's competition here

XXII plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, XXII stands at 1.3M. In comparison, UVV has a market cap of 1.3B. Regarding current trading prices, XXII is priced at $2.54, while UVV trades at $54.06.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

XXII currently has a P/E ratio of N/A, whereas UVV's P/E ratio is 14.43. In terms of profitability, XXII's ROE is -5.42%, compared to UVV's ROE of +0.07%. Regarding short-term risk, XXII is more volatile compared to UVV. This indicates potentially higher risk in terms of short-term price fluctuations for XXII.Check UVV's competition here

XXII plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, XXII stands at 1.3M. In comparison, ISPR has a market cap of 156M. Regarding current trading prices, XXII is priced at $2.54, while ISPR trades at $2.84.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

XXII currently has a P/E ratio of N/A, whereas ISPR's P/E ratio is -5.57. In terms of profitability, XXII's ROE is -5.42%, compared to ISPR's ROE of -1.68%. Regarding short-term risk, XXII is less volatile compared to ISPR. This indicates potentially lower risk in terms of short-term price fluctuations for XXII.Check ISPR's competition here

XXII plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, XXII stands at 1.3M. In comparison, KAVL has a market cap of 5.6M. Regarding current trading prices, XXII is priced at $2.54, while KAVL trades at $0.46.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

XXII currently has a P/E ratio of N/A, whereas KAVL's P/E ratio is -0.55. In terms of profitability, XXII's ROE is -5.42%, compared to KAVL's ROE of -0.70%. Regarding short-term risk, XXII is more volatile compared to KAVL. This indicates potentially higher risk in terms of short-term price fluctuations for XXII.Check KAVL's competition here

XXII plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, XXII stands at 1.3M. In comparison, GNLN has a market cap of 4.9M. Regarding current trading prices, XXII is priced at $2.54, while GNLN trades at $3.39.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

XXII currently has a P/E ratio of N/A, whereas GNLN's P/E ratio is N/A. In terms of profitability, XXII's ROE is -5.42%, compared to GNLN's ROE of -1.50%. Regarding short-term risk, XXII is more volatile compared to GNLN. This indicates potentially higher risk in terms of short-term price fluctuations for XXII.Check GNLN's competition here